Human Pharmaceutical Portfolio

Hivus-LR 50 mg/200 mg Tablet

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthRitonavir 50 mg + Lopinavir 200 mg
ManufacturerVeritaz Healthcare Ltd
CategoryAnti-Viral
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.